PortfoliosLab logoPortfoliosLab logo
ISIN
US0717711099

Highlights

Market Cap
$2.06B
Enterprise Value
$1.99B
EPS (TTM)
DKK 4.97
PE Ratio
11.70
PEG Ratio
0.16
Total Revenue (TTM)
DKK 5.66B
Gross Profit (TTM)
DKK 2.81B
EBITDA (TTM)
DKK 2.25B
Year Range
$8.67 - $13.00
ROA (TTM)
8.33%
ROE (TTM)
9.26%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Bavarian Nordic A/S ADR

Performance

BVNRY Performance Chart

Bavarian Nordic A/S ADR (BVNRY) is down 10.1% since the beginning of the year. At $9 per share, BVNRY is trading 31.4% below its 52-week high of $13. Investors who bought $1,000 worth of BVNRY shares 5 years ago would now be looking at an investment worth $607.


Loading charts...

S&P 500 Index

Returns By Period

Bavarian Nordic A/S ADR (BVNRY) has returned -10.13% so far this year and -0.04% over the past 12 months. Over the last ten years, BVNRY has returned -2.39% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Bavarian Nordic A/S ADR

1D
-2.83%
1M
-12.29%
YTD
-10.13%
6M
-10.08%
1Y
-0.04%
3Y*
-3.90%
5Y*
-9.51%
10Y*
-2.39%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BVNRY Monthly Returns History

Based on dividend-adjusted daily data since Feb 18, 2014, BVNRY's average daily return is +0.10%, while the average monthly return is +1.42%. At this rate, an investment would double in approximately 4.1 years.

Historically, 48% of months were positive and 52% were negative. The best month was Oct 2014 with a return of +59.5%, while the worst month was Mar 2020 at -49.6%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 5 months.

On a daily basis, BVNRY closed higher 30% of trading days. The best single day was May 19, 2022 with a return of +73.3%, while the worst single day was Sep 15, 2017 at -46.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20263.06%1.05%-3.99%-1.46%-1.23%-7.66%-10.13%
20254.18%-14.88%-6.54%9.49%9.49%1.85%35.75%2.97%-2.72%2.09%-22.04%4.10%14.01%
2024-11.95%-2.60%-0.93%-2.49%23.26%-7.50%7.75%47.64%-13.09%-9.08%-12.36%-4.33%-0.45%
20234.14%-3.03%-7.51%-3.69%-2.63%6.01%-23.82%3.49%0.01%-14.54%27.74%7.81%-13.84%
2022-19.33%-12.17%-12.17%-12.19%36.73%10.85%48.20%-24.23%-22.82%8.91%5.61%-8.60%-24.53%
20218.47%18.18%14.95%-6.19%2.69%-12.19%3.40%22.91%4.46%-11.08%1.14%-15.94%25.12%

Benchmark Metrics

Bavarian Nordic A/S ADR has an annualized alpha of 19.20%, beta of 0.41, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since February 18, 2014.

  • This stock participated in 105.92% of S&P 500 Index downside but only 61.80% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.41 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
19.20%
Beta
0.41
0.01
Upside Capture
61.80%
Downside Capture
105.92%

Return for Risk

Risk / Return Rank

BVNRY ranks 40 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


BVNRY Risk / Return Rank: 4040
Overall Rank
BVNRY Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
BVNRY Sortino Ratio Rank: 3838
Sortino Ratio Rank
BVNRY Omega Ratio Rank: 4040
Omega Ratio Rank
BVNRY Calmar Ratio Rank: 4242
Calmar Ratio Rank
BVNRY Martin Ratio Rank: 4141
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Bavarian Nordic A/S ADR (BVNRY) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BVNRYBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.03

Sortino ratioReturn per unit of downside risk

-2.49

Omega ratioGain probability vs. loss probability

1.05

1.37

-0.32

Calmar ratioReturn relative to maximum drawdown

-0.00

2.78

-2.79

Martin ratioReturn relative to average drawdown

-0.00

12.44

-12.44

Dividends

Dividend History


Bavarian Nordic A/S ADR doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Bavarian Nordic A/S ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bavarian Nordic A/S ADR was 77.80%, occurring on Apr 1, 2020. The portfolio has not yet recovered.

The current Bavarian Nordic A/S ADR drawdown is 60.70%.


Related event

Drawdown

Fall

Recovery

Underwater

COVID crash2020
-77.80%Apr 2020
2y 6mo
8y 9moSep 2017 - now
2016 bear market2016
-42.86%Nov 2016
1y 7mo5mo 4d
2y 16dApr 2015 - Apr 2017
2015 correction2015
-16.41%Feb 2015
27d29d
1mo 26dJan 2015 - Mar 2015
2014 pullback2014
-9.75%Dec 2014
1mo 1d1mo 5d
2mo 6dOct 2014 - Jan 2015
2015 pullback2015
-8.85%Mar 2015
6d8d
14dMar 2015 - Mar 2015

Drawdown Indicators


BVNRYBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-77.80%

-56.78%

-21.02%

Max Drawdown (1Y)

Largest decline over 1 year

-29.21%

-9.10%

-20.11%

Max Drawdown (3Y)

Largest decline over 3 years

-50.97%

-18.90%

-32.07%

Max Drawdown (5Y)

Largest decline over 5 years

-69.61%

-25.43%

-44.18%

Max Drawdown (10Y)

Largest decline over 10 years

-77.80%

-33.92%

-43.88%

Current Drawdown

Current decline from peak

-60.70%

-1.80%

-58.90%

Average Drawdown

Average peak-to-trough decline

-41.39%

-10.71%

-30.68%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.20%

2.03%

+15.17%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Bavarian Nordic A/S ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Bavarian Nordic A/S ADR is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for BVNRY, comparing it with other companies in the Biotechnology industry. Currently, BVNRY has a P/E ratio of 11.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for BVNRY compared to other companies in the Biotechnology industry. BVNRY currently has a PEG ratio of 0.2. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for BVNRY relative to other companies in the Biotechnology industry. Currently, BVNRY has a P/S ratio of 2.4. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for BVNRY in comparison with other companies in the Biotechnology industry. Currently, BVNRY has a P/B value of 1.1. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with BVNRY

Add Bavarian Nordic A/S ADR to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with BVNRY